Accumulation of Protease Mutations among Patients Failing Second-Line Antiretroviral Therapy and Response to Salvage Therapy in Nigeria

• Holly E. Rawizza ,

  * E-mail: hrawizza@hsph.harvard.edu

  Affiliations Brigham and Women’s Hospital, Boston, Massachusetts, United States of America, Harvard School of Public Health, Boston, Massachusetts, United States of America

  ⨯
• Beth Chaplin,

  Affiliation Harvard School of Public Health, Boston, Massachusetts, United States of America

  ⨯
• Seema T. Meloni,

  Affiliation Harvard School of Public Health, Boston, Massachusetts, United States of America

  ⨯
• Kristin M. Darin,

  Affiliation Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States of America

  ⨯
• Oluremi Olaitan,

  Affiliation AIDS Prevention Initiative in Nigeria, Abuja, Nigeria

  ⨯
• Kimberly K. Scarsi,

  Affiliation Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States of America

  ⨯
• Chika K. Onwuamah,

  Affiliation Nigerian Institute of Medical Research, Lagos, Nigeria

  ⨯
• Rosemary A. Audu,

  Affiliation Nigerian Institute of Medical Research, Lagos, Nigeria

  ⨯
• Philippe R. Chebu,

  Affiliation Jos University Teaching Hospital, Jos, Nigeria

  ⨯
• Godwin E. Imade,

  Affiliation Jos University Teaching Hospital, Jos, Nigeria

  ⨯
• Prosper Okonkwo,

  Affiliation AIDS Prevention Initiative in Nigeria, Abuja, Nigeria

  ⨯
• Phyllis J. Kanki

  Affiliation Harvard School of Public Health, Boston, Massachusetts, United States of America

  ⨯